Biocom has organized this panel discussion for anyone who is part of life sciences drug development, medical device, and diagnostics businesses to learn about the potential impact of health reform. Attendees will come away with a better understanding of key components of the Patient Protection and Affordable Care Act and how they affect market access and reimbursement of healthcare technologies; how changes will affect their industry sector; strategies for maximizing opportunities and for minimizing the threats of those changes; tactics that have worked or failed; and how to incorporate the changes into their market access or reimbursement planning for 2011 and beyond.